118 related articles for article (PubMed ID: 17314336)
1. DNA repair and survival in lung cancer--the two faces of Janus.
Gazdar AF
N Engl J Med; 2007 Feb; 356(8):771-3. PubMed ID: 17314336
[No Abstract] [Full Text] [Related]
2. ERCC1 and non-small-cell lung cancer.
Panasci L; Cohen V
N Engl J Med; 2007 Jun; 356(24):2540; author reply 2540-1. PubMed ID: 17575589
[No Abstract] [Full Text] [Related]
3. ERCC1 measurements in clinical oncology.
Reed E
N Engl J Med; 2006 Sep; 355(10):1054-5. PubMed ID: 16957152
[No Abstract] [Full Text] [Related]
4. ERCC1 and non-small-cell lung cancer.
Zhou SF
N Engl J Med; 2007 Jun; 356(24):2540; author reply 2540-1. PubMed ID: 17575590
[No Abstract] [Full Text] [Related]
5. [Clinical significance of ERCC1, RRM1 and TS in non-small cell lung cancer].
Li P; Kang X; Chen K
Zhongguo Fei Ai Za Zhi; 2014 Jun; 17(6):496-500. PubMed ID: 24949692
[No Abstract] [Full Text] [Related]
6. Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.
Hamilton G; Rath B
Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):17-24. PubMed ID: 29226731
[TBL] [Abstract][Full Text] [Related]
7. DNA repair by ERCC1 in non-small-cell lung cancer.
Cecere F; Bria E; Rosell R
N Engl J Med; 2006 Dec; 355(24):2590-1; author reply 2591. PubMed ID: 17167144
[No Abstract] [Full Text] [Related]
8. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.
Zheng Z; Chen T; Li X; Haura E; Sharma A; Bepler G
N Engl J Med; 2007 Feb; 356(8):800-8. PubMed ID: 17314339
[TBL] [Abstract][Full Text] [Related]
9. DNA repair by ERCC1 in non-small-cell lung cancer.
Grenader T; Shavit L
N Engl J Med; 2006 Dec; 355(24):2591; author reply 2591. PubMed ID: 17167936
[No Abstract] [Full Text] [Related]
10. Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer.
Okuda K; Sasaki H; Hikosaka Y; Kawano O; Yukiue H; Yano M; Fujii Y
J Surg Res; 2011 Jun; 168(2):206-12. PubMed ID: 20070981
[TBL] [Abstract][Full Text] [Related]
11. DNA repair by ERCC1 in non-small-cell lung cancer.
Wilcox JE
N Engl J Med; 2006 Dec; 355(24):2590; author reply 2591. PubMed ID: 17171818
[No Abstract] [Full Text] [Related]
12. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
[TBL] [Abstract][Full Text] [Related]
13. Applications of genomics in NSCLC.
Rosell R; Cobo M; Isla D; Sanchez JM; Taron M; Altavilla G; Santarpia M; Moran T; Catot S; Etxaniz O
Lung Cancer; 2005 Dec; 50 Suppl 2():S33-40. PubMed ID: 16557672
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between ERCC1 (C8092A) single nucleotide polymorphism and efficacy/toxicity of platinum based chemotherapy in Chinese patients with advanced non-small cell lung cancer.
KimCurran V; Zhou C; Schmid-Bindert G; Shengxiang R; Zhou S; Zhang L; Zhang J
Adv Med Sci; 2011; 56(1):30-8. PubMed ID: 21536539
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
[TBL] [Abstract][Full Text] [Related]
16. ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Booton R; Ward T; Ashcroft L; Morris J; Heighway J; Thatcher N
J Thorac Oncol; 2007 Oct; 2(10):902-6. PubMed ID: 17909351
[TBL] [Abstract][Full Text] [Related]
17. Phase II pharmacogenomics-based adjuvant therapy trial in patients with non-small-cell lung cancer: Southwest Oncology Group Trial 0720.
Bepler G
Clin Lung Cancer; 2007 Sep; 8(8):509-11. PubMed ID: 17948610
[No Abstract] [Full Text] [Related]
18. Pharmacogenomics: a reality or still a promise?
Bepler G
Lung Cancer; 2006 Dec; 54 Suppl 2(Suppl 2):S3-7. PubMed ID: 17064812
[TBL] [Abstract][Full Text] [Related]
19. RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC.
Vilmar A; Garcia-Foncillas J; Huarriz M; Santoni-Rugiu E; Sorensen JB
Lung Cancer; 2012 Mar; 75(3):306-12. PubMed ID: 21996087
[TBL] [Abstract][Full Text] [Related]
20. Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.
Zhou C; Ren S; Zhou S; Zhang L; Su C; Zhang Z; Deng Q; Zhang J
Jpn J Clin Oncol; 2010 Oct; 40(10):954-60. PubMed ID: 20462983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]